Application 208647
- Type
- NDA
- Sponsor
- SUN PHARMA GLOBAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EZALLOR | ROSUVASTATIN CALCIUM | CAPSULE;ORAL | EQ 5MG BASE | Yes | No |
| 002 | EZALLOR | ROSUVASTATIN CALCIUM | CAPSULE;ORAL | EQ 10MG BASE | Yes | No |
| 003 | EZALLOR | ROSUVASTATIN CALCIUM | CAPSULE;ORAL | EQ 20MG BASE | Yes | No |
| 004 | EZALLOR | ROSUVASTATIN CALCIUM | CAPSULE;ORAL | EQ 40MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208647-001 | EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | |
| N208647-002 | EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | |
| N208647-003 | EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | |
| N208647-004 | EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | |
| N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | |
| N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | |
| N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208647-001 | EZALLOR SPRINKLE | EQ 5MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208647-002 | EZALLOR SPRINKLE | EQ 10MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208647-003 | EZALLOR SPRINKLE | EQ 20MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208647-004 | EZALLOR SPRINKLE | EQ 40MG BASE | CAPSULE / ORAL | RLD | 2018-12-18 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208647-001 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208647-002 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208647-003 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208647-004 | 10413543 | 2036-02-12 | Drug product | 2019-10-09 | 5d02ea3f76ae… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Redpharm Drug | 5f848148-74a7-86c3-e063-6394a90af3a7 | 2026-11-05 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Novadoz Pharmaceuticals LLC | d58f1f63-4bb6-413c-9730-ded3e8078618 | 2026-10-28 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Umedica Laboratories USA Inc. | 989dffcf-0254-439d-9f3f-3b0e9d32de0a | 2026-10-23 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | NorthStar Rx, LLC | c622757d-7370-438b-8c2d-ef444a4f31dd | 2026-10-23 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | TORRENT PHARMACEUTICALS LIMITED | 6985e729-d963-4f32-89a1-727472b86daa | 2026-10-23 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Ascend Laboratories, LLC | 4ccbaa83-d57a-421e-88a8-1cee42d4207b | 2026-10-14 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | NuCare Pharmaceuticals, Inc. | 5d59114d-d0eb-bdf4-e063-6294a90af8b3 | 2026-10-08 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | b3c2df84-2d91-4e98-b079-e924d10899a0 | 2026-10-06 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Proficient Rx LP | 8bd56c80-2f98-4b6e-809e-d0e981c3dcb3 | 2026-10-01 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Torrent Pharmaceuticals Limited | 8c2d481f-53f2-4cf6-bd28-7d92323785cd | 2026-10-01 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Preferred Pharmaceuticals Inc. | 60d52228-f74f-46eb-85d2-e6b0cbb36092 | 2026-10-01 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | American Health Packaging | b7491a1a-570e-40ea-b65b-f956c9e284a6 | 2026-09-24 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | 0c919fc0-a3d7-4afb-968b-4ef0e447001c | 2026-09-21 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | cb942007-6ef1-4445-8dbd-6f4972148bf1 | 2026-09-09 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Rising Pharma Holdings, Inc. | 5c992d3d-d754-48b6-a267-1451208352ed | 2026-09-01 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | c607da3c-47f5-4773-8391-2a7b0826d30e | 2026-08-31 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | f230f4fe-0dbd-4062-9e11-a3e74bcdcba8 | 2026-08-31 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Aurobindo Pharma Limited | 47924917-bbd5-45de-96cb-c7ff9754da97 | 2026-08-28 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | 94245f53-2892-4209-8c94-c32c87d5b106 | 2026-08-27 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Preferred Pharmaceuticals, Inc. | 6ef51f7c-2899-4b09-bf8b-09e5b4ac3424 | 2026-08-26 | Warnings, Adverse reactions | ROSUVASTATIN CALCIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47335-984 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-984 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-984 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-984 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-985 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-985 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-985 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-985 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-986 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-986 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-986 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-986 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-987 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-987 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-987 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
| 47335-987 | EZALLOR SPRINKLE | ROSUVASTATIN | Sun Pharmaceutical Industries, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81254 | SUPPL | 2025-02-14 |
| 81238 | SUPPL | 2025-02-13 |
| 77909 | SUPPL | 2024-03-21 |
| 77897 | SUPPL | 2024-03-21 |
| 75018 | SUPPL | 2023-08-07 |
| 75017 | SUPPL | 2023-08-07 |
| 75016 | SUPPL | 2023-08-07 |
| 75015 | SUPPL | 2023-08-07 |
| 75014 | SUPPL | 2023-08-07 |
| 75013 | SUPPL | 2023-08-07 |
| 75008 | SUPPL | 2023-08-07 |
| 75007 | SUPPL | 2023-08-07 |
| 75006 | SUPPL | 2023-08-07 |
| 75005 | SUPPL | 2023-08-07 |
| 75004 | SUPPL | 2023-08-07 |
| 75003 | SUPPL | 2023-08-07 |
| 64721 | SUPPL | 2020-09-29 |
| 64708 | SUPPL | 2020-09-28 |
| 62608 | SUPPL | 2020-04-20 |
| 62598 | SUPPL | 2020-04-20 |
| 59643 | ORIG | 2019-08-09 |
| 58192 | SUPPL | 2019-04-02 |
| 58135 | SUPPL | 2019-03-29 |
| 56935 | ORIG | 2018-12-21 |
| 56799 | ORIG | 2018-12-19 |